Abstract
Background Healthcare workers have a greater exposure to individuals with confirmed SARS-novel Coronavirus 2, and thus a higher probability of contracting corona virus disease (CoViD)-19, than the general population. It is critically important, therefore, for health systems to protect the lives of their staff especially those on the frontline. Urgent work is needed to identify how best to protect those most at risk in an evidence-based way in order to implement protective allocations. We wished to explore the predictive role of basic demographics in order to establish a simple tool that could help risk stratify healthcare workers.
Objectives and Study question To develop a risk stratification tool for use to assist staff allocation by examining reported demographics of hospitalisation and mortality in the UK from CoViD-19 compared to population demographics and historic admissions for viral pneumoniae.
Setting Secondary Care in the UK and worldwide.
Participants Patients and Health Care Professionals hospitalised and dying of CoViD-19.
Methods We undertook a review of the published literature (including multiple search strategies in MEDLINE with PubMed interface) and critically assessed early reports on medRxiv, a pre-print server (https://www.medrxiv.org/) (date of last search: April 30, 2020). We explored the relative risk of mortality from readily available demographics in order to identify the population at highest risk.
Results The only published studies specifically assessing the risk of healthcare workers had limited demographics available, therefore we explored the general population in the literature.
Clinician Demographics. Mortality increased with increasing age from 50 years onwards. Male sex at birth, people of black and minority ethnicity groups had higher susceptibility to both hospitalisation and mortality.
Co-morbid Disease. Vascular disease, diabetes and chronic pulmonary disease further increased risk. Those with pre-existing mental health issues may also be more likely to experience emotional trauma, depression and anxiety with consequences for self-harm too. Risk stratification tool. A risk stratification tool was compiled using a Caucasian female <50years with no comorbidities as a reference. A point allocated to risk factors associated with an approximate doubling in risk. This tool provides numerical support for healthcare workers when determining which team members should be allocated to patient facing clinical duties compared to remote supportive roles.
Clinical Domain. Those working with aerosol generating procedures were at increased risk, however healthcare workers in any clinical domain are at higher risk than the general population.
Conclusions. We have generated a tool which can provide a framework for objective risk stratification of doctors and health care professionals during the CoViD-19 pandemic.
What this study adds
There is potentially an increased risk of mortality in the clinical workforce due to the effects of CoViD-19.
This manuscript outlines a risk stratification tool that may help quantify an individual’s personal risk
This may be used when allocating roles within clinical departments.
This tool does not incorporate other external factors, such as high-risk household members, that may require additional consideration when allocating clinical duties in an appropriate clinical domain.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations of Interest; None to declare by all authors
Funding; None
Data Availability
There is no new data - this represents an analysis of published data